Medical Scientist Training Program
Medical Scientist Training Program
批准号:
10214426
负责人:
ANDREA L COX
金额:
$5.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-07-01 至 2025-06-30
中文摘要
项目摘要
这是对约翰霍普金斯大学医学院医学科学家T32支持的申请
培训计划。我们MSTP的总体目标是培养出将使用强大、广泛的
医学教育和研究培训,通过高度创新的研究来改善健康,患者
关爱和教育。霍普金斯MSTP成立于1975年,在培训方面取得了令人瞩目的成功记录
内科科学家,并继续吸引高素质的申请者。节目收视率为410-528
2014年至2018年,每年完成二次申请,采访了其中约16%的人
申请者。挑选申请者参加面试和录取的过程是全面的,评估和
申请者独特的经历以及传统的学业成就衡量标准。大约12个
每年都有学生参加这个项目。被录取的学生平均GPA为3.91,平均MCAT
522分,并表现出对生物医学研究和临床医学职业生涯的高度动力。这个
获得学位的平均时间为8.2年,与全国平均水平持平。在MSTP现有的112名学生中,13%
在医学界的代表性不足。还将重点放在招收来自
弱势背景和残疾学生。学生通常需要两年的体检
在报名参加30个可供选择的研究生课程之前,先学习临床前科学课程
大约四年。我们的MSTP学生有1000多名研究人员,他们可以从他们中选择
博士生导师。在完成论文研究的同时,学生们继续从事临床教育并参加
高级课程。学生在返回医学专业之前平均发表7.6篇同行评议的论文
学校需要文员和选修课。安德里亚·考克斯,医学博士,自2013年以来一直指导该项目,
自2015年起与医学博士罗伯特·西里西亚诺共同担任董事。她是一名大学教授
医学和肿瘤学,传染病专家,活跃的基础科学和翻译研究人员,以及
尊敬的老师。考克斯博士领导着一个由38名成员组成的多元化的MD-PhD委员会,该委员会制定政策
该计划筛选和推荐录取申请者,并协助考克斯博士为学员提供建议
以及评估学生的进步。该计划非常成功地完成了MSTP的使命
培养优秀的内科科学家。2004至2004年间毕业的MSTP资助学生的比例
2019年,90%的人目前正在或已经完成临床实习,主要是顶级项目。其中
从完成研究生培训的那些年毕业的人中,80%的人仍然专注于研究
职业(74.7%的人从事研究,4.6%的人与研究有关)。最近的方案倡议包括
增加项目校友与在校学生的接触,加强学术努力以了解
扭转女性和其他群体在内科科学家职业中的代表性持续不足的局面,以及
使在校学生更多地接触到内科科学家的各种职业机会。
英文摘要
Project Abstract
This is an application for T32 support of The Johns Hopkins University School of Medicine Medical Scientist
Training Program. The overall goal of our MSTP is to produce MD-PhD leaders who will use a robust, broad
education in medicine and research training to improve health through highly innovative research, patient
care and education. The Hopkins MSTP, founded in 1975, has a remarkable record of success in training
physician scientists and continues to attract highly qualified applicants. The Program received 410-528
completed secondary applications annually between 2014 and 2018 and interviewed ~16% of these
applicants. The process of applicant selection for interviews and admission is holistic, assessing an
applicant’s unique experiences alongside traditional measures of academic achievement. Approximately 12
students enter the program each year. Admitted students have an average GPA of 3.91, an average MCAT
score of 522, and demonstrate high motivation for careers in biomedical research and clinical medicine. The
average time to degree matches the national average at 8.2 years. Of the 112 current MSTP students, 13%
are underrepresented in medicine. There is also substantial focus on the recruitment of students from
disadvantaged backgrounds and students with disabilities. Students typically take two years of medical
school preclinical science courses before enrolling in one of 30 available graduate programs for
approximately four years. Our MSTP students have over 1000 research faculty from whom they can select a
PhD mentor. While completing their thesis research, students remain engaged in clinical education and take
advanced courses. Students publish an average of 7.6 peer-reviewed papers before returning to medical
school required clerkships and electives. Andrea Cox, MD, PhD has been directing the program since 2013,
first as Co-Director with Robert Siliciano, MD, PhD, and as Director since 2015. She is a Professor of
Medicine and Oncology, infectious disease specialist, active basic science and translational researcher, and
distinguished teacher. Dr. Cox heads a diverse 38-member MD-PhD Committee that formulates policies for
the Program, screens and recommends applicants for admission, and assists Dr. Cox in advising trainees
and evaluating student progress. The Program has been highly successful in fulfilling the MSTP mission of
training outstanding physician scientists. Of the MSTP-supported students who graduated between 2004 and
2019, 90% are currently in or have completed clinical residencies, primarily in top-tier programs. Among
graduates from those years who have completed postgraduate training, 80 % remain in research-focused
careers (74.7% research intense and 4.6% research related). Recent programmatic initiatives include
increased engagement of Program alumni with current students, intensified scholarly efforts to understand
and reverse continued underrepresentation of women and other groups in physician scientist careers, and
increased exposure of current students to the full range of physician scientist career opportunities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Admin-Core-001
-
批准号:10710090
-
项目类别:
-
资助金额:$11.97万
-
财政年份:2022
-
负责人:ANDREA L COX
-
依托单位:
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
-
批准号:10614971
-
项目类别:
-
资助金额:$14.54万
-
财政年份:2021
-
负责人:ANDREA L COX
-
依托单位:
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
-
批准号:10205729
-
项目类别:
-
资助金额:$263.27万
-
财政年份:2021
-
负责人:ANDREA L COX
-
依托单位:
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
-
批准号:10205731
-
项目类别:
-
资助金额:$47.74万
-
财政年份:2021
-
负责人:ANDREA L COX
-
依托单位:
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
-
批准号:10398149
-
项目类别:
-
资助金额:$47.33万
-
财政年份:2021
-
负责人:ANDREA L COX
-
依托单位:
Immunologic and Metabolic Profiles of T cells that control diverse HCV infections
-
批准号:10398150
-
项目类别:
-
资助金额:$81.41万
-
财政年份:2021
-
负责人:ANDREA L COX
-
依托单位:
Sex, obesity, immunometabolism, and viral persistence in post-acute sequelae of SARS-CoV-2 infection
-
批准号:10554731
-
项目类别:
-
资助金额:$120.95万
-
财政年份:2021
-
负责人:ANDREA L COX
-
依托单位:
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
-
批准号:10205730
-
项目类别:
-
资助金额:$14.01万
-
财政年份:2021
-
负责人:ANDREA L COX
-
依托单位:
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
-
批准号:10398147
-
项目类别:
-
资助金额:$263.12万
-
财政年份:2021
-
负责人:ANDREA L COX
-
依托单位:
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
-
批准号:10398148
-
项目类别:
-
资助金额:$14.54万
-
财政年份:2021
-
负责人:ANDREA L COX
-
依托单位:
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
-
批准号:10671902
-
项目类别:
-
资助金额:$120.95万
-
财政年份:2021
-
负责人:ANDREA L COX
-
依托单位:
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
-
批准号:10614973
-
项目类别:
-
资助金额:$47.34万
-
财政年份:2021
-
负责人:ANDREA L COX
-
依托单位:
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
-
批准号:10614970
-
项目类别:
-
资助金额:$263.1万
-
财政年份:2021
-
负责人:ANDREA L COX
-
依托单位:
Immunologic and Metabolic Profiles of T cells that control diverse HCV infections
-
批准号:10205732
-
项目类别:
-
资助金额:$81.76万
-
财政年份:2021
-
负责人:ANDREA L COX
-
依托单位:
Immunologic and Metabolic Profiles of T cells that control diverse HCV infections
-
批准号:10614976
-
项目类别:
-
资助金额:$82.04万
-
财政年份:2021
-
负责人:ANDREA L COX
-
依托单位:
Project 1: Mechanisms of innate sensing and pathogenesis of SARS-CoV-2
-
批准号:10221908
-
项目类别:
-
资助金额:$81.53万
-
财政年份:2020
-
负责人:ANDREA L COX
-
依托单位:
Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS)
-
批准号:10855020
-
项目类别:
-
资助金额:$339.86万
-
财政年份:2020
-
负责人:ANDREA L COX
-
依托单位:
Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS)
-
批准号:10688356
-
项目类别:
-
资助金额:$207.93万
-
财政年份:2020
-
负责人:ANDREA L COX
-
依托单位:
Project 1: Mechanisms of innate sensing and pathogenesis of SARS-CoV-2
-
批准号:10688362
-
项目类别:
-
资助金额:$30.21万
-
财政年份:2020
-
负责人:ANDREA L COX
-
依托单位:
Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS)
-
批准号:10221904
-
项目类别:
-
资助金额:$406.72万
-
财政年份:2020
-
负责人:ANDREA L COX
-
依托单位:
海外基金